Impact Of Hospital-Acquired Infections On The Catheter-Related Bloodstream Infection Market: Pivotal Factor Influencing Catheter-Related Bloodstream Infection Market Growth in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Catheter-Related Bloodstream Infection Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been a significant increase in the market size for catheter-related bloodstream infection. The market will see a growth from $1.53 billion in 2024 to $1.62 billion in 2025, displaying a compound annual growth rate (CAGR) of 6.2%. The augmentation during the historical period is due to factors such as the escalating prevalence of chronic conditions, improved awareness and education, an increase in infections acquired from hospitals, the expansion of the geriatric population, and superior infection control protocols implemented in healthcare facilities and hospitals.

How Will the Catheter-Related Bloodstream Infection Market Size Evolve and Grow by 2029?
The market for catheter-related bloodstream infections is poised for significant expansion in the coming years, predicted to reach $2.05 billion by 2029, with a compound annual growth rate (CAGR) of 6.0%. This growth throughout the forecast period is partially due to the increase in healthcare-associated infections (hais), along with rising consciousness and educational efforts around infection control practices. Further contributing factors include the development of healthcare infrastructure, a growing elderly population, and government policies and initiatives that are supportive. There will also be a focus on key trends during this period, such as the innovation of biomaterials, advancements in smart catheter technology, creating more effective catheter lock solutions with superior antimicrobial features, novel sterilization methods for catheters, and the adoption of automatic flushing systems.

View the full report here:
https://www.thebusinessresearchcompany.com/report/catheter-related-bloodstream-infection-global-market-report

What Drivers Are Propelling the Growth of Catheter-Related Bloodstream Infection Market Forward?
An increase in hospital-acquired infections is anticipated to boost the expansion of the catheter-related bloodstream infection market. Hospital-acquired infections, often appearing 48 hours or more following a patient's admittance, are infections that patients contract while being treated for other conditions in a healthcare facility. Several factors, such as antimicrobial resistance, insufficient infection control methods, and patient vulnerability, contribute to the rise of these infections. Catheter-related bloodstream infections, due to their invasive qualities and microbial colonization potential, have a significant impact on hospital-acquired infections, particularly threatening to patients with permanently placed catheters. The National Library of Medicine, a US-based biomedical library, revealed in January 2023 that the global rate of healthcare-associated infection stood at 0.14%, with an annual increase of 0.06%. Therefore, the surge in hospital-acquired infections is projected to fuel the growth of the catheter-related bloodstream infection market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16646&type=smp

Which Emerging Trends Are Transforming the Catheter-Related Bloodstream Infection Market in 2025?
Leading entities in the catheter-related bloodstream infection market are in the process of creating advanced catheter lock systems to augment infection prevention and better patient results. A catheter lock solution is a fluid poured into a catheter to fend off infections and ensure the catheter remains viable between uses. For example, CorMedix Inc., an American biopharmaceutical firm dedicated to the development and distribution of therapeutic goods, gained approval from the US Food and Drug Administration in November 2023 for DefenCath, a catheter lock rig that utilizes taurolidine and heparin, designed for adult kidney failure patients requiring chronic hemodialysis via a central venous catheter (CVC). The antifungal and antimicrobial solution is created to decrease the occurrence of catheter-related bloodstream infections (CRBSIs), merging heparin's anticoagulant abilities with taurolidine's broad antimicrobial characteristics.

What Are the Key Segments in the Catheter-Related Bloodstream Infection Market?
The catheter-related bloodstream infection market covered in this report is segmented -

1) By Treatment: Antibiotic Lock Therapy, Anti-Microbial Agents
2) By Source Of Infection Or Causative Agents: Staphylococcus Aureus, Acinetobacter Baumannii, Escherichia Coli (E. Coli), Klebsiella Pneumoniae (K. Pneumonia), Candida Species (Candida Sp.), Pseudomonas Aeruginosa (P. Aeruginosa), Other Source Of Infection Or Causative Agents
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Antibiotic Lock Therapy: Catheter Lock Solutions (Antibiotic-based), Combination Antibiotic Lock Therapy
2) By Anti-Microbial Agents: Antibiotics, Antifungal Agents, Antiseptic Agents

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16646&type=smp

Who Are the Key Players Shaping the Catheter-Related Bloodstream Infection Market's Competitive Landscape?
Major companies operating in the catheter-related bloodstream infection market are Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG, 3M Company, Eli Lilly and Company, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company, Viatris Inc., B. Braun Medical Inc., Aurobindo Pharma Limited, Lupin Ltd., Xellia Pharmaceuticals Ltd., SteriMax Inc., Geistlich Pharma AG, Bactiguard AB, Hetero Healthcare Ltd., TauroPharm GmbH, Advacare Pharma, Citus Pharmaceuticals Inc., CorMedix Inc., JoinHub Pharma LLP, IntegraDose Compounding Services LLC

What Geographic Markets Are Powering Growth in the Catheter-Related Bloodstream Infection Market?
North America was the largest region in the catheter-related bloodstream infection market in 2023. The regions covered in the catheter-related bloodstream infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16646

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.